Inserting intra-aortic balloon pumps prior to angioplasty in patients with acute myocardial infarction does not reduce the scope of heart muscle damage, a condition referred to as infarct size, ...
MUNICH, Germany—Although use of an intra-aortic balloon pump (IABP) in patients with acute myocardial infarction (AMI) complicated by cardiogenic shock appears safe, the technique does not improve ...
DUBLIN--(BUSINESS WIRE)--The "US Market Report for Intra-Aortic Balloon Pumps 2018 - MedCore" report has been added to Research and Markets' offering. An intra-aortic balloon pump system is used for ...
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/wrkmn3/china_cardiac) has announced the addition of the "China Cardiac ...
LIMERICK, Pa.--(BUSINESS WIRE)-- Teleflex Incorporated (NYSE:TFX), a leading global provider of medical devices for critical care and surgery, has announced a new agreement with HealthTrust Purchasing ...
Getinge heart balloon pumps further deflated by 4 more Class I recalls and 6 reported patient deaths
In a flurry of Aug. 31 notices from the FDA, the number of Class I recalls plaguing Getinge’s Cardiosave intra-aortic balloon pumps this year has doubled. The notices detailed four more recalls of the ...
WAYNE, Pa., April 01, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced FDA 510(k) clearance of the AC3 Range™ Intra-Aortic ...
The FDA placed some balloon pumps on its medical device shortage list Dec. 2, which the agency said was because of increased demand and shortage of some of the product’s components. There is a ...
Intra-aortic balloon pump (IABP) therapy fails to reduce infarct size or improve clinical outcomes when added prior to primary percutaneous coronary intervention (PCI) in patients with high-risk ...
Getinge’s intra-aortic balloon pumps seem to have lost their rhythm: Already this year, the devices have been the target of a handful of FDA Class I recalls in the U.S. and a CE mark suspension in ...
Getinge is recalling 4,338 intra-aortic balloon pumps after discovering fluid leaks that can lead to unexpected shutdowns or the inability to initiate therapy, the FDA said Dec. 16. The agency has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback